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Abstract
Background:Working in healthcare is often considered a risk factor for influenza; however, this risk has not been quantified.
We aimed to systematically review evidence describing the annual incidence of influenza among healthy adults and
healthcare workers (HCWs).
Methods and Findings: We searched OVID MEDLINE (1950 to 2010), EMBASE (1947 to 2010) and reference lists of identified
articles. Observational studies or randomized trials reporting full season or annual influenza infection rates for healthy,
working age adult subjects and HCWs were included. Influenza infection was defined as a four-fold rise in antibody titer, or
positive viral culture or polymerase chain reaction. From 24,707 citations, 29 studies covering 97 influenza seasons with
58,245 study participants were included. Pooled influenza incidence rates (IR) (95% confidence intervals (CI)) per 100 HCWs
per season and corresponding incidence rate ratios (IRR) (95% CI) as compared to healthy adults were as follows. All
infections: IR 18.7 (95% CI, 15.8 to 22.1), IRR 3.4 (95% CI, 1.2 to 5.7) in unvaccinated HCWs; IR 6.5 (95% CI, 4.6 to 9.1), IRR 5.4
(95% CI, 2.8 to 8.0) in vaccinated HCWs. Symptomatic infections: IR 7.5 (95% CI, 4.9 to 11.7), IRR 1.5 (95% CI, 0.4 to 2.5) in
unvaccinated HCWs, IR 4.8 (95% CI, 3.2 to 7.2), IRR 1.6 (95% CI, 0.5 to 2.7) in vaccinated HCWs.
Conclusions: Compared to adults working in non-healthcare settings, HCWs are at significantly higher risk of influenza.
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Introduction
One frequently postulated risk factor for influenza infection is
being a healthcare provider [1]. Outbreaks of influenza in long
term care facilities are very common, occurring in as many as 50%
of facilities each year [2], and there have been numerous reports of
outbreaks of influenza in acute care hospitals [3]. The assumption
of transmission of influenza from patients to healthcare workers
(HCWs) and vice versa seems obvious, as influenza is transmitted
primarily by close contact, and many HCWs have close contact
with persons ill due to influenza. On the other hand, influenza is
also very common in the community mainly because children are
most often affected, and household transmission of influenza is
frequent [4–8]. Only one study during a single season has
prospectively assessed the risk of serologically proven influenza
infection associated with HCW status in a large, multicenter
cohort. Although no association was found, the upper bound of the
confidence interval of the point estimate did not exclude a
potentially large increase in risk [9]. Studies of influenza risk
comparing HCWs to other adults are challenging in that adequate
sample sizes are difficult to achieve, and other risk factors for
adults are not well described. However, many studies have
reported rates of influenza in working adults, and others have
reported rates among HCWs. We aimed to systematically review
evidence describing the annual incidence of influenza among
healthy adults and HCWs, and to evaluate the hypothesis that
influenza incidence rates are higher in HCWs than in other
healthy, community-dwelling adults.
Materials and Methods
We follow the meta-analyses of observational studies in
epidemiology (MOOSE) guidelines for reporting our results [10].
Because of relative lack of direct comparative studies between
HCWs and non-HCW adults, we extrapolated information
regarding risk of influenza among both populations from
individual studies and performed meta-analyses of rates.
Search strategy
We identified all relevant studies in the English language
literature, searching OVID MEDLINE (from 1950 to September
2010) and EMBASE (from 1947 to September 2010) with the help
of an experienced librarian (detailed search strategy provided in
Data S1). We also searched reference lists of included studies. We
did not include conference proceedings, abstracts, theses, disser-
tations or national or local vital statistics data not published as peer
reviewed articles.
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Study selection
Inclusion criteria. Observational studies (cohort and case-
control studies) or randomized trials (studies of vaccines where
data from each arm were analyzed separately for vaccinated and
unvaccinated participants) that reported on healthy, working age
adult subjects (as per the study definition, or persons 18 to 64 years
of age) or HCWs with asymptomatic or symptomatic influenza
infection who were assessed prospectively over one or more
complete influenza seasons were included.
Studies must also have measured influenza infection by at least
one of the following methods: (a) a four-fold rise in antibody titer
comparing serum drawn pre- and post-season; (b) a four-fold rise
in antibody titer comparing acute and convalescent serum
obtained systematically from participants with acute respiratory/
influenza-like illness; (c) culture or (d) PCR of nasopharyngeal
aspirates or swabs obtained systematically from participants with
acute respiratory/influenza-like illness.
Exclusion criteria. Case reports and case series where the
denominator population could not be determined, studies that
reported incidence rates in military personnel, college or university
students, or persons in remote or isolated communities; outbreak
reports; studies in which data for adults 18 to 64 years of age could
not be separated from data for older adults and/or children (unless
children accounted for ,2% or older adults ,10% of the study
population, according to our a priori definition), studies with a
duration of less than one complete influenza season, and studies of
a single influenza strain or type only (unless the studied strain was
reported to account for .90% of all circulating strains in the
seasons studied) were excluded.
Selection. One review author (SPK) inspected the abstract of
each reference identified by the search and selected the studies for
full review. All possibly relevant articles were then inspected for
inclusion in full by two review authors (SPK and AM).
Discrepancy was resolved by consensus.
Data extraction
Data from included studies were independently extracted by
two reviewers; SPK (all studies) and one of the other reviewers
(AM, BC, AW or PL), using a standardized data collection form.
A third reviewer was consulted in case of disagreement between
the two data extractors and discrepancy was resolved by
consensus.
Data from included studies on year of publication, influenza
seasons (years) under study, circulating influenza subtypes, study
design, population (HCWs vs. adults working in non-healthcare
settings vs. adults living with children in their households), country
of origin, vaccination status of participants, diagnostic methods,
number of subjects studied and number infected based on the
outcome measures of interest (see below) were collected. When
available from the reported results in the studies, data specifically
for subjects 18 to 64 years of age were extracted.
Outcome
The outcome measures of interest were the incidence rate of
symptomatic infection and that of all infection (symptomatic and
asymptomatic). Symptomatic infection was defined as acute illness
consistent with influenza (as defined in each study), together with
laboratory evidence for influenza (PCR or culture yielding
influenza virus, or a four-fold or greater rise in antibody titer).
All influenza infection was defined as a four-fold or greater rise in
antibody titer over the influenza season, with or without other
diagnostic tests, regardless of clinical symptoms.
Assessment of risk of bias
Risk of bias among included studies was assessed in the domains
of patient selection, outcome assessment and attrition by SPK
(adapted from Newcastle-Ottawa Scale [11,12], assessment of
quality of included studies tool provided in Table S1). Overall risk
of bias was assessed by selecting the greatest risk of bias among
these three domains. Existing literature suggested that our
exposures of interest (HCW status versus other adults working in
non-healthcare settings) only sporadically matched that of
published studies. Rather, other exposures, such as vaccination
status, were commonly assessed in subpopulations that corre-
sponded to our exposures of interest. Therefore, the full
Newcastle-Ottawa scale [12], which mainly focuses on quality of
exposure and outcomes, did not comply with the requirements for
this study question.
Data synthesis and analysis
A priori, we planned a stratified meta-analysis because of
anticipated clinical heterogeneity among included studies. Sub-
group categories were: symptomatic versus all infections; vacci-
nated versus unvaccinated participants; and studies of adults in
households with children versus other studies of adults; and, within
the subgroup of symptomatic infections: influenza symptoms with
acute/convalescent or pre-/post-season serology versus PCR with
or without viral culture versus viral culture alone.
Strata with at least two eligible studies were synthesized by
conducting a meta-analysis of incidence rates. Variances around
estimates of incidence rates from various studies were calculated.
Binomial confidence intervals were calculated using SAS (version
9?1, SAS Institute, Cary, NC). Appropriate subgroups were meta-
analyzed using inverse of variance for calculating weight for each
estimate in the meta-analysis. The meta-analysis was performed
using Review Manager software (RevMan version 5?0. Copenha-
gen: The Nordic Cochrane Centre, The Cochrane Collaboration,
2008). Because we anticipated heterogeneity between studies, a
random-effects model was used for all analyses. Statistical
heterogeneity was initially inspected graphically (forest plot) and
assessed by calculating tests of heterogeneity using the Cochran Q
test (Chi-square test). We quantified the degree of heterogeneity
using the I2 statistic [13]. We also calculated incidence rate ratio
(with 95% confidence interval [CI]) between vaccinated and
unvaccinated adults and HCWs for the outcomes of all infections
and symptomatic infections, respectively, using the delta method
[14].
In secondary analysis, we asked whether differences in incidence
could be detected between seasons in which different influenza
subtypes (A/H1N1, A/H3N2 or B) predominated, and, for
symptomatic infections, whether the incidence was different in
studies with a requirement for fever (temperature $37.8uC) in the
definition of influenza-like-illness.
Results
A total of 7,763 (OVID MEDLINE) and 16,944 (EMBASE)
titles and abstracts were screened, and 124 full articles were
retrieved. Of these, 29 studies satisfied eligibility criteria and were
included in the meta-analysis [5,9,15–41]. Characteristics of
included studies are presented in Tables S2 and S3. Excluded
studies and reasons for exclusion are listed in Data S2. Overall risk
of bias was minimal in two studies [37,39], low in 17 studies
[5,15,16,19–25,29–31,33,38,40,41], moderate in eight studies
[9,17,26,27,32,34–36], and high in two studies (Table S4) [18,28].
The included studies had data from a total of 97 influenza
seasons between 1957 and 2009 with a total of 58,245 participants
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(18,131 subjects for all infections, and 40,114 subjects for
symptomatic infections, respectively). Nine studies (38 influenza
seasons, 13,373 participants) assessed influenza rates in HCWs
[9,19,20,27–29,36,40,41], seven studies (20 influenza seasons,
3,642 participants) enrolled families with children [5,21–24,26,31],
and 14 studies (39 influenza seasons, 41,230 participants) assessed
influenza rates in adults not working in healthcare settings and
irrespective of family status [15–18,20,25,30,32–35,37–39]. From
these, one study provided data for both HCWs and non-HCWs
without comparison [20]. One other study compared HCWs to
non-HCWs directly, but the non-HCW group did not fit our
inclusion and exclusion criteria as college students were included
in the non-HCW group [9].
Figures 1, 2 and 3 depict the influenza incidence rates in
HCWs, adults working in non-healthcare settings and adults living
in households with children, respectively. Pooled incidence rates of
all subgroups, according to subpopulation, vaccination status, and
diagnostic methods are presented in Table 1. No differences in
incidence could be detected based on predominant influenza
subtype in the study, or a requirement for fever in the definition of
influenza-like illness (data not shown). Rates and 95% CI for all
influenza infections ranged from 1.2% (95% CI, 0.9% to 1.7%)
per season in vaccinated working adults to 24.2% (95% CI, 15.1%
to 38.9%) in unvaccinated adults with exposure to children,
whereas those for symptomatic infections ranged from 0.4% (95%
CI, 0.1% to 1.6%) in vaccinated HCWs diagnosed by viral culture
only to 20.8% (95% CI, 13.8% to 31.6%) in adults with exposure
to children and unknown vaccination status, diagnosed by acute/
convalescent or pre-/post-season serology. There was considerable
heterogeneity within the subgroups: the only subgroup without
significant heterogeneity was that of all infections in vaccinated
working age adults, which included only two studies (I2 = 16%,
P=0.28).
Incidence rate of influenza in HCWs and healthy, working
adults
Unvaccinated and vaccinated HCWs were compared to
healthy, working adults with the same vaccination status by
subgroup meta-analyses for all infections and symptomatic
infections, respectively, using serology for influenza diagnosis
(Table 2). There were too few data to compare studies of other
subgroups. In all four subgroups, incidence rates in HCWs were
higher than in working adults. Incidence rate ratios were higher
for all infections than for symptomatic infections. Rates of all
infections were found to be lower in vaccinated HCWs than in
those who were unvaccinated.
Discussion
Our systematic review and meta-analyses of influenza incidence
in HCWs and other healthy adults suggests that HCWs are at
higher risk for influenza infection as compared to healthy adults
working in non-healthcare settings. We found that the incidence
rates of unvaccinated as well as vaccinated individuals with
serologically proven, combined symptomatic and asymptomatic
influenza is higher among HCWs than non-HCWs. However, we
could not find a difference in the incidence of symptomatic
influenza infection between HCWs and other working adults,
although there was a trend to higher infection rates in HCWs, and
the confidence limits do not exclude a 2.5 fold increase in risk.
One potential explanation of the finding that HCWs are at higher
risk of asymptomatic but not symptomatic influenza infection
might be that their cumulative exposure to influenza (or influenza
vaccine) over time is higher than that of other workers, so that
prior immunity reduces symptom severity.
Our results also suggest that, among the populations studied,
HCWs have similar risk to working age adults living in households
with children, and that familial exposure to children substantially
increases the risk of infection among non-HCWs, although, in
accordance with our data analysis strategy, direct comparisons
could not be performed and thus, these results should be
interpreted with caution. It is well-known from family studies that
influenza incidence is higher in children than in adults
[21,22,24,26], and observational studies have shown that living
with children increases the risk for laboratory-confirmed influenza
infection [9,42]. Our results confirm that familial exposure to
children should be taken into account when assessing influenza
risk in routine clinical practice and controlled for in research
studies. They also suggest that one mechanism of reducing the risk
of failing to meet end-points in influenza vaccine efficacy trials in
adults may be to selectively recruit adults with known familial
exposure to children [25].
We were unable to locate any other systematic review or meta-
analyses of influenza incidence in adults. Only one prospective
observational study has directly compared influenza rates in
HCWs and non-HCWs [9]. This study compared the incidence of
influenza, as measured by influenza-like-illness and pre- and post-
season serology among hospital healthcare workers and other
working adults during the 2006/7 influenza season in Berlin,
Germany. No difference in either symptomatic or asymptomatic
influenza infection was identified in this cohort, although HCWs
had an increased risk of acute respiratory infection (OR=3.0,
P=0.04), and were more likely to have a pre-season antibody titer
of $40 to influenza A/H3N2, suggesting greater exposure in prior
seasons. One possibility for the differences between our study and
that of Williams et al. is unmeasured differences in exposures to
influenza, either in HCWs or other working adults. Although
Williams et al. asked about overall person-contacts at work, work
contacts with children may be particularly important (e.g. working
in a daycare center) in working adults. Similarly, all hospital
HCWs may not have the same risk of infection, and different types
of HCWs may have been included in different studies.
Our study is important in that quantification of influenza risk in
HCWs, particularly those working in acute care, is needed to
support decisions regarding priorities for influenza vaccination and
antiviral treatment or prophylaxis during pandemics. In addition,
understanding influenza incidence in HCWs is important for
implementation of infection control measures to reduce influenza
transmission in hospitals. To date, four randomized controlled
trials have now shown that vaccination of HCWs in long-term care
is associated with a substantial decrease in mortality among
residents [43–46]. If HCWs are indeed at particularly high risk for
asymptomatic influenza infection, the greatest risk to frail elderly
patients in hospitals may be from workers who are asymptomat-
ically infected; vaccination then becomes the only strategy that will
confer patient protection. The results of our study thus provide
another strong argument for supporting universal influenza
vaccination of hospital HCWs.
Figure 1. Forest plot of influenza incidence rates in healthcare workers. Squares and horizontal lines through the squares represent
incidence rates with 95% confidence intervals. Abbreviations: IV, inverse variance; CI, confidence interval; HCWs, healthcare workers; PCR, polymerase
chain reaction.
doi:10.1371/journal.pone.0026239.g001
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We anticipated heterogeneity between the studies due to
variability in influenza rates from year to year, due to differences
in predominating influenza strains from year to year, as well as to
differences in study design. Therefore, we stratified our analyses
according to exposure to children, vaccination status and diagnostic
methods used, and pooled the weighted estimates of each study in
these subgroups only. Incidence rates across different influenza
subtypes were pooled as no difference between incidences in studies
with different predominant subtypes could be detected. Neverthe-
less, there was substantial heterogeneity within subgroups. We
suggest that this heterogeneity is partly related to study methodology
(e.g. the variability in symptom complexes that resulted in specimen
collection in symptomatic individuals), cross-reactive immunity
between the previous vaccine strains, previous circulating strains
and the new circulating strains and to the match of the influenza
vaccine to the circulating strains in vaccinated individuals. Due to
the complex cross-reactive immunity with previous circulating and
vaccine strains, and the wide confidence limits on the proportion of
infections due to any one subtype in individual studies, we did not
attempt to further stratify for match of vaccine in those vaccinated.
Strengths of our study include the careful literature search and
data collection, and a priori decision to perform subgroup meta-
analyses only in the face of known clinical heterogeneity. This
study also has limitations. First, we limited our search to two
main databases and to the English literature for logistical reasons.
Influenza incidence is often not the primary outcome of interest
in these studies, necessitating a broad search strategy and wide
screening. Nevertheless, we believe that we have sufficiently
covered the existing literature for this study question. Second,
newer diagnostic techniques may result in different findings for
the detection of symptomatic influenza infection; given their
greater sensitivity to lower viral loads (as may be seen in mild
infection), it is possible that findings of studies using PCR
detection in mild acute respiratory illness to define symptomatic
infection will be different that those using culture and influenza-
like-illness as a definition. Third, the existing tool for assessment
of risk of bias of observational studies, the Newcastle Ottawa
Scale [12], was not completely applicable. The tool that we thus
needed to develop is not validated [11]. Fourth, even though we
attempted to address potential confounding originating from
Figure 2. Forest plot of influenza incidence rates in adults working in non-healthcare settings. Squares and horizontal lines through the
squares represent incidence rates with 95% confidence intervals. Abbreviations: IV, inverse variance; CI, confidence interval; PCR, polymerase chain
reaction.
doi:10.1371/journal.pone.0026239.g002
Figure 3. Forest plot of influenza incidence rates in adults sharing their households with children. Squares and horizontal lines through
the squares represent incidence rates with 95% confidence intervals. Abbreviations: IV, inverse variance; CI, confidence interval; PCR, polymerase
chain reaction.
doi:10.1371/journal.pone.0026239.g003
Incidence of Influenza Infection
PLoS ONE | www.plosone.org 6 October 2011 | Volume 6 | Issue 10 | e26239
pooling incidence rates by performing stratified analyses, some
potential confounders could not be accounted for. As an example,
we were unable to stratify for influenza seasons, taking into
account variations of influenza rates over time. Nevertheless, we
believe that our statistical analysis is robust enough to detect a
difference originating from HCW status alone. Finally, as with all
indirect meta-analyses, the comparisons in this study are indirect:
data were obtained from different arms of various eligible studies,
and the pooled incidence rates may not be directly comparable
between groups. Limitations applicable to all indirect meta-
Table 1. Influenza incidence rates according to subpopulation, diagnostic methods and vaccination status.
Subpopulation Diagnostic methods Vaccination status
Number
of
seasons
Number
of
Subjects I2 (P value)
Incidence rate [95%
confidence interval]
(n/100 population/season)
Families1 All infections Unvaccinated 1 62 NA 24.19 [15.05, 38.89]
Unknown 9 1,951 81% (,0.001) 13.56 [10.25, 17.94]
Symptomatic infections (serology) Unknown 1 96 NA 20.83 [13.75, 31.56]
Symptomatic infections (culture) Unknown 9 1,533 79% (,0.001) 4.96 [2.82, 8.71]
Working adults All infections Unvaccinated 4 4,373 93% (,0.001) 5.44 [3.01, 9.84]
Vaccinated 2 3,717 16% (0.28) 1.20 [0.86, 1.68]
Unknown 6 2,479 91% (,0.001) 9.13 [5.95, 14.01]
Symptomatic infections (serology) Unvaccinated 4 1,234 66% (0.03) 5.12 [3.08, 8.52]
Vaccinated 3 2,619 68% (0.04) 3.04 [1.79, 5.15]
Unknown 2 1,446 63% (0.10) 1.22 [0.48, 3.05]
Symptomatic infections (culture) Unvaccinated 8 9,393 90% (,0.001) 2.91 [1.78, 4.75]
Vaccinated 8 14,017 89% (,0.001) 1.35 [0.76, 2.41]
Symptomatic infections (PCR) Unvaccinated 1 325 NA 10.77 [7.76, 14.94]
Vaccinated 1 1,627 NA 5.16 [4.17, 6.40]
HCWs All infections Unvaccinated 10 2,273 66% (0.002) 18.69 [15.80, 22.11]
Vaccinated 8 3.026 73% (,0.001) 6.49 [4.63, 9.09]
Unknown 1 250 NA 11.20 [7.76, 16.17]
Symptomatic infections (serology) Unvaccinated 7 1,857 81% (,0.001) 7.54 [4.86, 11.70]
Vaccinated 7 3,092 76% (,0.001) 4.81 [3.23, 7.16]
Unknown 1 250 NA 8.00 [5.12, 12.49]
Symptomatic infections (culture) Unvaccinated 2 1,505 99% (,0.001) 6.24 [0.83, 46.88]
Vaccinated 1 698 NA 0.43 [0.11, 1.61]
Symptomatic infections (PCR) Unknown 1 422 NA 2.37 [1.22, 4.61]
Abbreviations: CI, confidence interval; NA, not applicable; HCWs, healthcare workers.
1Working-age adults living in households with children.
doi:10.1371/journal.pone.0026239.t001
Table 2. Incidence rates and incidence rate ratios of influenza infection of healthcare workers and non-healthcare workers from
subgroup meta-analyses, according to vaccination status and diagnostic methods.
Vaccination
status Diagnostic methods Subpopulation
Number of
seasons
Number of
subjects
Incidence rate [95%
confidence interval]
(n/100 population/
season)
Incidence Rate Ratio
[95% confidence
interval]
Unvaccinated All infections HCWs 10 2,273 18.69 [15.80, 22.11] 3.43 [1.20, 5.67]
Working adults 4 4,373 5.44 [3.01, 9.84]
Vaccinated All infections HCWs 8 3,026 6.49 [4.63, 9.09] 5.41 [2.79, 8.03]
Working adults 2 3,717 1.20 [0.86, 1.68]
Unvaccinated Symptomatic infections (serology) HCWs 7 1,857 7.54 [4.86, 11.70] 1.47 [0.44, 2.50]
Working adults 4 1,234 5.12 [3.08, 8.52]
Vaccinated Symptomatic infections (serology) HCWs 7 3,092 4.81 [3.23, 7.16] 1.58 [0.49, 2.67]
Working adults 3 2,619 3.04 [1.79, 5.15]
Abbreviations: HCWs, healthcare workers.
doi:10.1371/journal.pone.0026239.t002
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analyses are relevant to our results as well and caution is
warranted in interpretation.
In conclusion, our systematic review and meta-analysis provides
valuable insights in the dynamics of influenza infection in adults.
Our data suggest that HCWs are at higher risk of acquiring
influenza infection as compared to adults working in non-
healthcare settings, and that the rate of asymptomatic infections
in particular might be considerably higher in HCWs. Adequately
powered, prospective cohort studies that directly compare
influenza rates in HCWs to those of working adults in non-
healthcare settings are needed to confirm our findings. Addition-
ally, future research should focus on the identification of high-risk
subgroups among HCWs and other working adults.
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